Visp, Switzerland

Olwen M Birch


Average Co-Inventor Count = 8.8

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Naters, CH (2000)
  • Visp, CH (2000 - 2008)

Company Filing History:


Years Active: 2000-2008

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Olwen M Birch: Innovator in Biotechnology

Introduction

Olwen M Birch is a notable inventor based in Visp, Switzerland. He has made significant contributions to the field of biotechnology, holding a total of 9 patents. His work focuses on innovative processes and methods that enhance the production of various chemical compounds.

Latest Patents

Among his latest patents is an enzyme for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives. This invention relates to a novel process for preparing specific amino alcohol derivatives and introduces microorganisms capable of utilizing cyclopentene derivatives as their sole nitrogen or carbon source. Another significant patent is a method for producing trifluoro-3(R)-hydroxybutyric acid derivatives. This biotechnological method utilizes microorganisms or cell-free enzyme extracts to produce these derivatives from trifluoroacetoacetic acid.

Career Highlights

Olwen M Birch is currently employed at Lonza AG, a leading global provider of integrated solutions for the pharmaceutical and biotechnology industries. His work at Lonza AG has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in biotechnology.

Collaborations

Throughout his career, Olwen has collaborated with several talented individuals, including Eva Maria Urban and Frank Brux. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Olwen M Birch's contributions to biotechnology through his patents and work at Lonza AG highlight his role as an influential inventor in the field. His innovative approaches continue to pave the way for advancements in chemical production and microbial utilization.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…